Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
14.18
-0.80 (-5.34%)
At close: Feb 21, 2025, 4:00 PM
14.29
+0.11 (0.78%)
After-hours: Feb 21, 2025, 7:30 PM EST
Myriad Genetics Employees
Myriad Genetics had 2,700 employees as of December 31, 2023. The number of employees increased by 100 or 3.85% compared to the previous year.
Employees
2,700
Change (1Y)
100
Growth (1Y)
3.85%
Revenue / Employee
$305,037
Profits / Employee
-$42,963
Market Cap
1.29B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
MYGN News
- 3 days ago - Myriad Genetics Included in Forbes America's Best Employers 2025 List - GlobeNewsWire
- 16 days ago - Myriad Genetics and CancerCARE for Life Announce Agreement to Advance Access to MyRisk with RiskScore Hereditary Cancer Test - GlobeNewsWire
- 17 days ago - Myriad Genetics Announces Two New Patents Granted for its Molecular Residual Disease (MRD) Assay - GlobeNewsWire
- 17 days ago - Myriad Genetics and Lumea Collaborate to Enhance Access to the Prolaris Biomarker and MyRisk Hereditary Cancer Tests through BxLink Integration - GlobeNewsWire
- 24 days ago - Myriad Genetics Unveils Groundbreaking Eight Weeks' Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference - GlobeNewsWire
- 4 weeks ago - Myriad Genetics Introduces Online Prenatal Genetic Testing Resource - GlobeNewsWire
- 4 weeks ago - Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology - GlobeNewsWire
- 5 weeks ago - Diligent Announces Market Insights Reporting Powered by S&P Global Market Intelligence, Giving Directors and Executives Unrivaled Financial and Risk Insights - Business Wire